• 1
    Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Pajak TF. A randomized phase I/II trial of hyperfractionated radiotherapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with ≧ 69.6 Gy in favourable patients with Radiation Therapy Oncology Group Stage III non-small cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol. 1990; 8: 15431555.
  • 2
    Haffty BG. Is radiation therapy a viable alternative to surgery in early stage lung cancer? Int J Radiat Oncol Biol Phys. 1990; 19: 223224.
  • 3
    Sandler HM, Curran WJ, Turrisi AT 3rd. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1990; 19: 913.
  • 4
    Dillman RO, Herndon J, Seagren SL, Eaton WL Jr., Green MR. Improved survival in stage III non-small cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst. 1996; 88: 12101215.
  • 5
    Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst. 1991; 83: 417423.
  • 6
    Sause WT, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst. 1995; 87: 198205.
  • 7
    Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991; 21: 109122.
  • 8
    Kihlstrom L, Karlsson B, Lindqvist C. Gamma knife surgery for cerebral metastases. Implications for survival based on 16 years' experience. Stereotact Funct Neurosurg. 1993; 61: 4550.
  • 9
    Flickinger JC, Kondoziolka D, Lunsford LD, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys. 1994; 28: 797802.
  • 10
    Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Acta Oncol. 1995; 34: 861870.
  • 11
    Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. Cancer. 1998; 82: 10621070.
  • 12
    Arimoto T, Usubuchi H, Matsuzawa T, et al. Small volume multiple non-coplanar arc radiotherapy (SMART) for tumors of the lung, head and neck and the abdominopelvic region. In: LemkeHU, VannierMW, InaumraK, FarmanA, editors. Computer assisted radiology and surgery '98.). Amsterdam: Elsevier Science, 1998: 257259.
  • 13
    SobinLH, WittekindC, eds. UICC TNM classification of malignant tumors, 5th ed. New York: John Wiley, 1997.
  • 14
    Travis WD, Colby TV, Corrin B, Shimosato Y. Histological classification of lung and pleural tumors. In: TravisWD, ColbyTV, CorrinB, ShimosatoY. Histological typing of lung and pleural tumors, 3rd ed. Heidelberg: Springer-Verlag, 1999: 2166.
  • 15
    LENT-SOMA Tables. Radiother Oncol. 1995; 35: 1760.
  • 16
    Arimoto T, Takamura A, Tomita M, Suzuki K, Hosokawa M, Kaneko Y. Intraoperative radiotherapy for esophageal carcinoma — significance of IORT dose for the incidence of fatal tracheal complication. Int J Radiat Oncol Biol Phys. 1993; 27: 10631067.
  • 17
    Shirato H, Takamura A, Tomita M, et al. Stereotactic irradiation without whole-brain irradiation for single brain metastasis. Int J Radiat Oncol Biol Phys. 1997; 37: 385391.
  • 18
    Sakamoto S, Arimoto T. Spatial parameters and the organ tolerance in stereotactic multiple arc radiotherapy: JASTRO research group report. J Jastro. 1998; 10: 153160.
  • 19
    Nakagawa K, Aoki Y, Tago M, Terahara A, Ohtomo K. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys. 2000; 48: 449457.
  • 20
    Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen: methodological aspects. Acta Oncol. 1994; 33: 677683.
  • 21
    Sato M, Uematsu M, Yamamoto F. Feasibility of frameless stereotactic high-dose radiation therapy for primary or metastatic liver cancer. J Radiosurg. 1998; 1: 233238.
  • 22
    Ohara K, Okumura T, Akisada M, et al. Irradiation synchronized with respiration gate. Int J Radiat Oncol Biol Phys. 1989; 17: 853857.
  • 23
    Shimizu S, Shirato H, Kagei K, et al. Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. Int J Radiat Oncol Biol Phys. 2000; 46: 11271133.
  • 24
    Tada T, Minakuchi K, Fujioka T, et al. Lung cancer: intermittent irradiation synchronized with respiratory motion — results of a pilot study. Radiology. 1998; 207: 779783.
  • 25
    Shirato H, Shimizu S, Kunieda T, et al. Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys. 2000; 48: 11871195.
  • 26
    Seppenwoolde Y, Shirato H, Kitamura K, et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys. 2002; 53: 82234.
  • 27
    Marks LB, Munley MT, Spencer DP, et al. Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys. 1997; 38: 399409.
  • 28
    Armstrong J, Raben A, Zelefsky M, et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol. 1997; 44: 1722.
  • 29
    Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncl Biol Phys. 1999; 45: 323329.
  • 30
    Sunyach MP, Falchero L, Pommier P, et al. Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small cell lung cancer: preliminary results. Int J Radiat Oncol Biol Phys. 2000; 48: 459463.
  • 31
    Fan M, Marks LB, Hollis D, et al. Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? J Clin Oncol. 2001; 19: 543550.